We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

8th Circ. Revives Class Action Over KV Recalls

Law360 (January 19, 2011, 3:56 PM EST) -- The Eighth Circuit on Wednesday revived a class action against KV Pharmaceutical Co. over its recalls of hypertension drug metoprolol succinate ER, finding that the plaintiffs' claims are not preempted by federal law.

The U.S. Court of Appeals for the Eighth Circuit said that the Federal Food, Drug and Cosmetic Act does not preempt the plaintiffs' claims for breach of implied warranty of merchantability or violations of Missouri law.

The three-judge panel rejected KV's argument that the claims were preempted because they were based on violations...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.